"Visit the UCLA Health website for coronavirus updates."

During the past decade, UCLA Burbank conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Burbank" #1 collaborator was "Translational Research in Oncology" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Burbank" are "Early Breast Cancer" (2 trials). Many other conditions were trialed in "UCLA Burbank" in a lesser frequency.

Most popular intervention types in "UCLA Burbank" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (1 trials), "Endocrine Therapy" (1 trials), "Giredestrant" (1 trials), "Palbociclib" (1 trials) and "Ribociclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Burbank" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "UCLA Burbank". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UCLA Burbank, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Burbank, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".